Don’t invest unless you’re prepared to lose all the money you invest. This is a high-risk investment and you are unlikely to be protected if something goes wrong. Take 2 mins to learn more.
alt text
Sutherland Health Group Ltd
Company Name:Sutherland Health Group Ltd Minimum fundraise:£0.00* High Share Price Bid:£0.35
Business Sector:Pharmaceuticals, healthcare and biotechnology Total Funds Bid to Date:- Low Share Price Bid:£0.01
Auction period:30 May 2019 - 14 Aug 2019 Indicative Share Price:0.00 Average Share Price Bid:£0.26**
*The company will accept oversubscription.
**In the event of significant oversubscription, shares will be allocated to bids at the average price and above.
NOTE: ASSET MATCH HAS NEGOTIATED AN “ASSET MATCH INVESTOR BONUS” FOR INVESTORS IN THIS TRANSACTION. SEE THE “OVERVIEW” SECTION BELOW FOR DETAILS.

Need help?
+44 (0) 207 248 2788

back

Sutherland Health Group Ltd

Trading in the shares of Sutherland Health Group Ltd has been suspended with immediate effect as of the 15th August 2019.

Updates to follow in due course.

Please direct any queries to dealing@assetmatch.com or call 020 7248 2788.

Interested in Sutherland Health Group Ltd?
Register or log in to participate, create a watchlist, or set reminder

Company info

Sutherland Health Group Limited has been a leading supplier to the UK National Health Service (NHS) and medical sector for over 20 years. It is a trusted British manufacturer and supplier of maternity, personal care, nutrition, sexual health, manual handling and gynaecological diagnostic products to the medical market within the UK and Europe. 

The Group is committed to developing and marketing high quality products and brands that will benefit health professionals and consumers alike. The Group’s own established brands include; babskin® and Sutherland® baby toiletries, Sutherland® Lubricating Jelly, Vision® diagnostics and Biston® manual handling products.

The Group proudly manufactures the majority of its products in the United Kingdom and is ISO and MHRA registered with quality at the core of it business. 

Sutherland Health Group Limited is the holding company for Sutherland Health Ltd and Condomania Plc.

History 

Sutherland Health Group Plc was formed in October 2004 by George Sutherland and was originally known as Sexual Health Group Plc. The Group changed its name to Sutherland Health Group Plc in October 2008 as the business developed and broadened the products offered.

The Group completed a funding round and joined the ICAP Securities & Derivatives Exchange - ISDX on 10th January 2005 and joined the Asset Match Private Market in 2016. The group has seen an increase in its shareholder base that now includes investment funds as well as several private investors.

The Group acquired Sutherland Health Ltd in March 2006 and Biston product in 2013. In 2016 the Group made the change from becoming a Plc to a Limited company following the admission to AM Private Market.

The Group specialises in consulting with medical professionals and government bodies to develop and source innovative products that are manufactured to its own specifications.
 



Auction Details

Sutherland Health Limited were admitted to trading on Asset Match on 30th March 2016 at a price 0.7 pence per share.

Auctions are held quarterly and close at 4pm on the last Wednesday of the month. The first scheduled auction is due to close on the 27th April 2016 with another adhoc auction taking place throughout May 2016 as agreed with the company.  Following which the calendar will revert to quarterly from May 2016 (unless stated otherwise).

Participants can send orders via their existing broker or directly to The Share Centre. Further details can be found by clicking on the "Auction instructions" section below.


Price history (last 10)

Enlarge

Auction instructions

To buy and sell shares in this company via Asset Match Private Market, you will need to use a stockbroker.

           -  shareDeal active

If you are a UK resident, our main broker and settlement agent for all CREST eligible companies on the AM Private Market is shareDeal active.

shareDeal active provide a competitively priced service for both certified and non-certified transactions. You can open an account online or by post using the form provided.

Alternatively, if you already have an account with shareDeal active and wish to place an order please contact the Dealing desk directly on 01892 510515 or deal online.

To sell a share certificate, the easiest way to trade is to set up a shareDeal active account online and once open post your share certificate with a completed CREST transfer form. Alternatively, you can open an account by post using the Asset Match Certificated Sale Pack which includes everything you will need.

It generally takes 5-7 days for your account to be open and shares available for trading.

           -  Already have a stockbroker

Over 60 UK brokers regularly trade and are set up to deal on our platform. These brokers can submit your instructions to shareDeal active on your behalf*.

Please note that not all brokers are able to deal in unquoted shares so contact us to confirm whether your broker is able to trade.

           -  Overseas

If you are based overseas and are interested in participating then please contact us directly by emailing dealing@assetmatch.com or by calling 020 7248 2788.

​​When buying and selling shares, please note that the Asset Match levy of 3% applies, with a minimum charge of £20 per trade (*additional fees may apply).

For more information on how the auction works then please click here.

 

 

Key People

George

George Sutherland Chief Executive Officer

Appointed October 2004 George previously worked in sales and management roles for Associated Biscuits; Nabisco; Bristol-Myers Squibb; Chesebrough Ponds; Unilever; Mates Healthcare Ltd and Ansell Ltd before setting up his own business. He is also a Director of Langdales Ltd.

   

Sheena Sukumaran Marketing Director

Appointed October 2004 Sheena previously worked in marketing for Taylor & Francis Plc (Informa Plc) and Sutherland Health Ltd. She is also a Director of Langdales Ltd.